# Does Terlipressin Improve Renal Outcome After Liver Surgery

> **NCT02368249** · PHASE2 · WITHDRAWN · sponsor: **University of Zurich**

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02368249
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no focus on this topic
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368249, "Does Terlipressin Improve Renal Outcome After Liver Surgery". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02368249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*